pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Hepatology · news · pharmadog
← back to Hepatology
News · Hepatology
122
stories
May 13, 26
STAT+: A new kind of liver crisis is emerging in the U.S. The American diet is to blame
stat
May 12, 26
Honesty and Humor Provide Hope in Breast Cancer Survivorship: With Sara Nunnery, MD, MSCI; and Annie Bond
onclive
May 12, 26
GU Cancer Experts Highlight Top Abstracts to Watch During ASCO 2026
onclive
May 12, 26
STAT+: Despite its toll, alcohol is still an awkward subject in the doctor’s office
stat
May 12, 26
STAT+: Alcohol is wreaking havoc on U.S. public health. American society looks the other way
stat
May 12, 26
6 takeaways from STAT’s investigation into the U.S. alcohol epidemic
stat
May 11, 26
Rezdiffra is exceeding Wall Street's expectations as the MASH market takes shape
endpoints
May 11, 26
GSK cuts deal with Sino to broaden reach of hepatitis B drug
biopharma dive
May 9, 26
The OncFive: Top Oncology Articles for the Week of 5/3
onclive
May 8, 26
Dr Randall on Long-Term Responses and Functional Benefits With Pimicotinib in TGCT
onclive
May 7, 26
STAT+: Angelini Pharma buys Catalyst Pharmaceuticals and its rare disease drugs for $4.1B
stat
May 6, 26
STAT+: Oregon hospitals won’t outsource to national physician chain after all
stat
May 6, 26
Dr Sznol on Biomarkers of Response in Metastatic Melanoma
onclive
May 6, 26
STAT+: Color Health moving deeper into cancer services, complete with virtual ‘tumor boards’
stat
May 6, 26
Avalo shares spike on skin drug data; BioNTech to cut staff
biopharma dive
May 6, 26
STAT+: Novo Nordisk’s less-bad news on its Wegovy pill boosts earnings and share price
stat
May 5, 26
Intercept's next-gen FXR agonist fails Phase 2 in latest setback for Italian-owned pharma
endpoints
May 5, 26
STAT+: A new attack on AMA’s billing codes
stat
May 5, 26
STAT+: Are analysts too quick to gloss over Lilly’s liver case?
stat
May 5, 26
Madrigal extends MASH deal streak with Arrowhead drug that J&J didn't want
endpoints
May 1, 26
Two biotechs raise a combined $556M in latest spurt of IPOs
biopharma dive
Apr 30, 26
STAT+: New obesity tool aims to predict risk of 18 serious complications
stat
Apr 29, 26
FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech
biopharma dive
Apr 28, 26
Boehringer dual-acting obesity shot hits mark in Phase 3 trial
biopharma dive
Apr 28, 26
Opinion: It’s time to seize the rare bipartisan opening to address microplastics
stat
Apr 27, 26
New U.S. recommendation on hepatitis B vaccine will have dire consequences, studies project
stat
Apr 27, 26
Intellia CRISPR drug succeeds in late-stage study against rare swelling disorder
biopharma dive
Apr 24, 26
Sanofi MS drug rejected in US gets an endorsement in Europe
biopharma dive
Apr 24, 26
Opinion: The local news crisis is also a public health crisis
stat
Apr 23, 26
Sanofi posts upbeat sales as R&D pressure builds
biopharma dive
← prev
page 4 of 5
next →
